Related Experiment Video
Updated: Sep 20, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Toll like receptor 4 gene Asp299Gly polymorphism increases the risk of diabetic microvascular complications: a meta
Yuqi Zhang1,2, Huanhuan Li1,2, Chenyi Wang1,2
1Department of Endocrinology, The First Hospital of Lanzhou University, No. 1 Donggang West Road, Lanzhou, 730000, Gansu, People's Republic of China.
Objective:
The relationship between Toll like receptor 4(TLR4) gene Asp299Gly polymorphism and diabetic microvascular complications (DMI) is unclear. Therefore, the aim of this meta analysis was to explore the relationship between TLR4 Asp299Gly polymorphism and DMI.
Methods:
System search PubMed, Web of science, Springer, Cochrane library, ELSEVIER, Wanfang database, VIP, CNKI, a case-control study of the correlation between TLR4 gene Asp299Gly polymorphism and DMI published before June 2020 was collected.
Results:
We included 6 articles, a total of 11 studies involving patients with type 2 diabetes mellitus (T2DM) complicated by microvascular complications 1834 cases, without corresponding microvascular complications 4069 cases. TLR4 gene Asp299Gly polymorphism increased the risk of microvascular complications in T2DM (dominant model OR = 1.52, 95% CI 1.10-2.09, p = 0.01; allelic model OR = 1.42, 95% CI 1.02-1.96, p = 0.04). Subgroup analysis by race and different type of microvascular complications, we found that TLR4 gene Asp299Gly polymorphism was associated with increased risk of microvascular complications in the Caucasian population (dominant model OR = 1.69, 95% CI 1.22-2.35, P = 0.002; allelic model OR = 1.56, 95% CI 1.10-2.21, P = 0.01) and increased the risk of retinopathy in patients with T2DM(dominant model OR = 1.81, 95% CI 1.04-3.14, P = 0.03; allelic model OR = 1.77, 95% CI 1.05-2.98, P = 0.03).
Conclusion:
TLR4 gene Asp299Gly polymorphism was associated with increased risk of microvascular complications in patients with T2DM, especially diabetic retinopathy (DR).
Insights
The Toll like receptor 4 (TLR4) Asp299Gly gene variant increases the risk of microvascular complications in type 2 diabetes. This risk is particularly elevated for diabetic retinopathy in Caucasian populations.
Area of Science:
- Genetics
- Immunology
- Endocrinology
Background:
- Diabetic microvascular complications (DMI) are a major cause of morbidity in type 2 diabetes mellitus (T2DM).
- The role of genetic factors, such as Toll like receptor 4 (TLR4) gene polymorphisms, in DMI development requires further elucidation.
Purpose of the Study:
- To conduct a meta-analysis investigating the association between the TLR4 gene Asp299Gly polymorphism and DMI in patients with T2DM.
- To explore potential subgroup differences based on ethnicity and specific microvascular complications.
Main Methods:
- A systematic literature search was performed across multiple databases (PubMed, Web of Science, Springer, Cochrane Library, ELSEVIER, Wanfang, VIP, CNKI) for case-control studies.
- Studies published before June 2020 correlating TLR4 Asp299Gly polymorphism with DMI were included.
Main Results:
- The meta-analysis included 6 articles comprising 11 studies (1834 cases with DMI, 4069 controls).
- TLR4 Asp299Gly polymorphism was significantly associated with an increased risk of DMI in T2DM patients (dominant model OR=1.52, P=0.01; allelic model OR=1.42, P=0.04).
- Subgroup analyses revealed a stronger association in Caucasians and an increased risk of diabetic retinopathy (DR).
Conclusions:
- The TLR4 gene Asp299Gly polymorphism is linked to a higher risk of microvascular complications in T2DM patients.
- This genetic variant is particularly associated with an increased risk of diabetic retinopathy.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Diabetes Mellitus: Type 2 and Gestational
Dipeptidyl Peptidase 4 Inhibitors
Coronary Artery Disease I: Introduction
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

